Cancer trials: Search results
Results: 151 items found. Showing page 3 of 6.
Refine results
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined With Clinico-Pathological Features
Trial short name: ELISA
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Other
A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence
Trial short name: EMBER-4
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence
Trial short name: EMBER-4
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination with Tremelimumab ± Lenvatinib Given Concurrently with Transarterial Chemoembolization (TACE) Compared to TACE Alone in Patients with Locoregional Hepatocellular Carcinoma
Trial short name: EMERALD-3
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
EPIK-O: A Phase III, Multi-center, Randomized (1:1), Open-label, Active-controlled, Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Olaparib as Compared to Single Agent Cytotoxic Chemotherapy, in Participants With no Germline BRCA Mutation Detected, Platinum-resistant or Refractory, High-grade Serous Ovarian Cancer
Trial short name: EPIK-O
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Trial short name: eVOLVE-Lung02
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician’s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)
Trial short name: EvoPAR-Prostate01
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase I Trial of the Combination of Olaparib and Navitoclax in Women with High Grade Serous Epithelial Ovarian Cancer and Triple Negative Breast Cancer
Trial short name: EXACTIS-03
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 1
A Phase I Trial of the Combination of Olaparib and Navitoclax in Women with High Grade Serous Epithelial Ovarian Cancer and Triple Negative Breast Cancer
Trial short name: Exactis-03
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 1
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations
Trial short name: F8394-201
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
A Multicenter, Randomized, Double-Blind, Phase 2, Basket Study of MK-4280A, a Coformulation of Favezelimab (MK-4280) with Pembrolizumab (MK-3475) in Selected Solid Tumors (KeyForm-010)
Trial short name: FAVE SCC
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 2
Feasibility of Integrating Rectal Hydrogel Spacer for Salvage Treatment using STereotactic Ablative Body Radiotherapy for Locally Recurrent Prostate Cancer (FIRST STAR)
Trial short name: FIRST STAR
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
Phase II Trial of Fecal Microbial Transplantation in Patients with Advanced Non-Small Cell Lung Cancer and Melanoma Treated with Immune Checkpoint Inhibitors
Trial short name: FMT-LUMINate
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 2
Phase II Trial of Fecal Microbial Transplantation in Patients with Advanced Non-Small Cell Lung Cancer and Melanoma Treated with Immune Checkpoint Inhibitors
Trial short name: FMT-LUMINate
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 2
A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab plus Chemotherapy versus Placebo plus Chemotherapy in Subjects with Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer with FGFR2b Overexpression (FORTITUDE-101)
Trial short name: FORTITUDE 101
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression
Trial short name: FORTITUDE-102
Cancer type: Gastrointestinal
Cancer location: Stomach / Gastric
Disease stage: Early Cancer
Trial phase: Phase 3
An International, Seamless Phase II/III Responsive Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Trial short name: GBM AGILE
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
Magnetic resonance imaging as a tool to adapt concurrent chemoradiation treatment for malignant gliomas
Trial short name: GBMSM1
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
A Phase 1/2, Open-Label, Dose-Escalation Trial of GEN3013 in Patients with Relapsed, Progressive or Refractory B-Cell Lymphoma (Genmab 01)
Trial short name: Genmab 01
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Trial short name: Geron MDS Imerge
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Early Cancer
Trial phase: Phase 2, Phase 3
A Phase II Study of the Rate of Conversion to Complete Resection in Patients with Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination with Best Systemic Chemotherapy
Trial short name: HAIP-6192
Cancer type: Gastrointestinal
Cancer location: Colorectal
Disease stage: Advanced Cancer
Trial phase: Phase 2
Sunnybrook Hematology Biobank (CMH Biobank)
Trial short name: Heme Biobank
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase:
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Trial short name: HN.11
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 3
HSIL/ACIS/Early Cervical Cancer: What Are The Current Causative HPV Subtypes in the Era of HPV Vaccination?
Trial short name: HPV Subtypes
Cancer type: Gynecology
Cancer location: Cervix
Disease stage: Early Cancer
Trial phase: Other
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
Trial short name: HPVDNA02
Cancer type: Gynecology
Cancer location: Cervix
Disease stage: Early and Advanced Cancer
Trial phase: Other
